Fig. 5
From: Construction of a novel quinoxaline as a new class of Nrf2 activator
In vitro anti-inflammatory activity of TD-1 on RAW 264.7 cells. The effect of TD-1 on a cell viability; b LPS stimulated nitrite production; c LPS stimulated IL-1β production; d LPS stimulated 1L-6 production; e LPS stimulated TNF-α production and f LPS stimulated PGE2 production. In a; *Significant difference (P < 0.05) with respect to the cells (DMSO + LPS) treatment. In b–f; *Significant difference with respect to the cells (only DMSO treatment), #Significant difference with respect to the cells (LPS + DMSO) treatment